Sheldon L. Koenig, President and CEO at Esperion Therapeutics, Inc. (ESPR), sold 56,854 shares at $2.79 ($159K) on 2025-09-17, disclosed to the SEC on 2025-09-18.
Open-market sale of $159k ESPR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.79 | 28,427 | $79K | 50.0% |
| 2 | $2.79 | 28,427 | $79K | 50.0% |
| Total | $2.79 avg | 56,854 | $159K | 100% |
| Filing → |
| ESPR | SELL | 2025-12-18 | $354K | — | Filing → |
| ESPR | SELL | 2025-06-18 | $34K | — | Filing → |
| ESPR | SELL | 2025-03-19 | $20K | — | Filing → |